5 people die during obesity treatment with gastric balloons
US Food and Drug Administration has issued a safety alert to healthcare providers after five deaths were reported from 2016 to present in patients with liquid-filled intragastric balloon systems used to treat obesity. In three reports, death occurred within one to three days of the balloon placement, however, the root cause was not definitely attributed to the procedure, FDA said.